Anti-HoxC6 Rabbit Monoclonal Antibody for WB, ELISA - P09630

Core Product Specifications and Parameters

Biological Background: HoxC6 Function and Localization

• HOXC6 is a member of the homeobox family of transcription factors that regulate anterior-posterior body axis patterning during embryonic development.
• The protein contains a conserved homeodomain that enables sequence-specific DNA binding, allowing it to control the expression of target genes involved in cell fate determination.
• HOXC6 is predominantly localized to the nucleus, consistent with its role as a transcription factor.
• Alternative splicing of the HOXC6 gene generates multiple transcript variants, potentially contributing to functional diversity.
• As a developmental protein, HOXC6 is critical for proper embryonic morphogenesis and tissue specification.

Experimental Guidance and Technical Tips

• The immunogen corresponds to the N-terminal region (amino acids 1–100), outside the conserved homeodomain; this may offer isoform-specific detection.
• Recommended for Western blot (WB) and ELISA; for other applications (e.g., immunofluorescence, chromatin immunoprecipitation), consider optimization under relevant experimental conditions.
• Species cross-reactivity includes human, mouse, and rat, supporting use in common mammalian model systems.
• The predicted molecular weight is approximately 27 kDa (UniProt calculated mass ~26.9 kDa); confirm migration with appropriate molecular weight markers as post‑translational modifications or splice variants may shift the band.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio provides a one‑stop sourcing solution for IVD raw materials, offering this anti‑HOXC6 rabbit monoclonal antibody alongside validated antibody pairs, optimized mono‑/polyclonal antibodies, and bulk ancillary reagents. Whether you are developing assays for developmental biology research or require reliable immunodetection tools, our supply network covers everything from routine consumables to rare‑target raw‑material sourcing, bridging the gap from concept to clinic.